High-Efficacy DMTs: Transforming MS Care
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Ahmed Z. Obeidat, MD, PhD
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
PROs in MS: A New Era of Patient-Centric Care
From Pathology to Practice: The Role of Inflammation in MS Pathology
Long-Term Safety of DMTs: What We Know and What We Need to Know
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Fluid Biomarkers: Revolutionizing MS Diagnosis
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
Balancing Act: Immune Reconstitution vs Immune Suppression
Imaging Biomarkers: MS Progression in Focus
Schizophrenia Care: Improving Social Cognition and Motivation
Michael Green, PhD
FcRn Inhibitors: A Potential New Targeted Therapy Option
Nicholas J. Silvestri, MD
The Evolving gMG Treatment Landscape
Henry Kaminski, MD
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.